Medetomidine/ketamine anaesthesia in cats

Area of Science:

• Veterinary Anesthesiology
• Small Animal Surgery

Background:

• Ketamine is a common anesthetic agent in cats, but it has limitations including poor muscle relaxation and inadequate visceral analgesia.
• Alternative anesthetic combinations are frequently sought to improve the quality and safety of anesthesia in feline patients.

Purpose of the Study:

• To evaluate the efficacy and safety of the medetomidine/ketamine combination as a sole anesthetic agent for feline ovariectomy.
• To compare the medetomidine/ketamine combination with other commonly used anesthetic protocols in cats.

Main Methods:

• Sixty cats undergoing ovariectomy were divided into six groups (10 animals each).
• Anesthetic protocols included medetomidine/ketamine, acepromazine/ketamine, xylazine/ketamine, and zolazepam/tiletamine.
• Anesthetic duration, muscle relaxation, visceral analgesia, and cardiovascular effects were assessed.

Main Results:

• Medetomidine/ketamine provided anesthesia of comparable duration to xylazine/ketamine and zolazepam/tiletamine, and longer than acepromazine/ketamine.
• Superior muscle relaxation and visceral analgesia were observed with medetomidine/ketamine compared to acepromazine/ketamine and zolazepam/tiletamine.
• While ketamine's stimulant effect counteracted medetomidine's bradycardia, this combination, like xylazine/ketamine, induced bradycardia, unlike the other combinations.

Conclusions:

• The medetomidine/ketamine combination is a suitable anesthetic for feline ovariectomy, offering rapid induction, good muscle relaxation, and effective analgesia.
• This combination effectively mitigates ketamine's primary drawbacks, providing a balanced anesthetic profile.
• Medetomidine/ketamine results in bradycardia, a factor to consider during anesthetic monitoring.